welcome to oneGRAVESvoice- a positively charged Graves' disease and thyroid eye disease community.
- join today!
- log in
Join us for a free discussion on living with and managing thyroid eye disease.
Topics include symptoms, management and treatment options for thyroid eye disease and the patient experience.
Holly Chang, MD, FACS
Clinical Associate Professor
University of Washington, Seattle, WA, USA
Layla Lohmann, DDS
Dallas, Texas, USA
Date & Time:
Wednesday, September 22, 2021
07:00 PM in Eastern Time (US and Canada)
This event has ended.
Relation Between Therapy for Hyperthyroidism and the Course of Graves’ OphthalmopathyBackground: The chief clinical characte...
Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye DiseasePurpose: To present an update on the ef...
Teprotumumab for Thyroid-Associated OphthalmopathyBackground: Thyroid-associated ophthalm...
Efficacy of B-cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves’ Orbitopa...Background: Preliminary studies have sh...
Which Factors are Associated With Quality of Life in Patients With Graves’ Orbitopathy Presenting for Orbital ...Purpose: Graves' orbitopathy (GO) is as...
Patients’ Expectations for the Functional and Psychosocial Outcomes of Orbital Decompression Surgery for Thyro...Patients with appearance-altering condit...
Related Quality of Life Questionnaire Specific to Dysthyroid Ophthalmopathy Evaluated in a Population of Patients Wi...Objective: The aim of this study was to...